Vir Biotechnology, Inc. Appoints Mark D. Eisner as Executive Vice President and Chief Medical Officer, Effective June 3, 2024

Vir Biotechnology, Inc. announced that Mark D. Eisner, M.D., M.P.H. will join the company as Executive Vice President and Chief Medical Officer , effective June 03, 2024. Dr. Eisner will be a part of...

Related Keywords

California ,United States ,Stanford University ,China ,Sonoma Biotherapeutics ,Markd Eisner ,School Of Public Health ,Sonoma Biotherapeutics Inc ,Genentech ,Management Team ,Global Head Of Product Development Immunology ,Vir Biotechnology Inc ,University Of Pennsylvania School Medicine ,University Of California Berkeley ,Vir Biotechnology ,Executive Vice President ,Chief Medical Officer ,Executive Management Team ,Marianne De Backer ,Chief Executive ,Senior Vice President ,Global Head ,Product Development Immunology ,Infectious Disease ,Pennsylvania School ,California Berkeley ,